Systemic inflammatory reaction (SIR) is an unfavorable prognostic factor in many
malignancies and has a role in all stages of the neoplastic process: initiation, promotion, and …

Objective To assess the prognostic value of the systemic immune-inflammation index (SII) in
patients with vulvar cancer. Methods Data of 130 consecutive patients who underwent …

Background Systemic immune-inflammation index (SII) has been suggested to be effective
to reflect the inflammatory status and thus may be an underlying biomarker for prognosis …

At the level of the genital system, ovarian neoplasm is the most frequent cause of morbidity
and mortality. In the specialized literature, the coexistence of an inflammatory process is …

We investigated the association between preoperative ratios of inflammatory markers and
the prognosis in patients with invasive cervical cancer (CC). In this single-centre study, we …

Systemic inflammation indices were found to be correlated with therapeutic outcome in
several cancers. This study retrospectively analyzes the predictive role of a broad range of …

It has been confirmed that the systemic inflammation response index (SIRI) based on
peripheral blood neutrophil, monocyte and lymphocyte counts can be used for the …

Inflammation contributes to development and progression in a variety of cancers, including
cervical cancer. We developed a novel cervical cancer systemic inflammation score (CCSIS) …

Chronic inflammation is an aberrantly prolonged form of a protective response to a loss of
tissue homeostasis and it is involved in several steps of the carcinogenesis process. As a …

The systemic immune-inflammation index (SII) based on peripheral lymphocyte, neutrophil
and platelet counts has been considered a good index that reflects the local immune …